The European Commission has recently published a comprehensive package of regulatory reforms for the pharmaceutical sector in the European Union (EU), setting out a legislative action plan and strategic vision that seeks to balance greater patient access, improved regulatory efficiency, and the need to boost the Life Sciences sector’s global competitiveness. Join us, Tim Wilsdon and Anthony Barron, as we explore some of the key components of the new Pharmaceutical Strategy for Europe and set out some of the policy initiatives stemming from the strategy.
Drug price controls in the US: A roundtable discussion with experts
The United States is the world leader in innovative drug development, supporting patients and health systems globally by advancing the creation of new cures...